4
Changes in Ownership
TREACE MEDICAL CONCEPTS, INC. Filed Acc 0000950170-25-042291
Chief Innovation Officer sold 50,000 shares at $7.97 ($398,460)
- Chief Innovation Officer acquired 50,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Scanlan Sean F. · Chief Innovation Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +50,000 | $1.05 | $52,500 | 414,081 | D |
| 2025-03-17 | Sale : show line 2 in the form 10b5-1 | −50,000 | $7.97 | $398,460 | 364,081 | D |
| Open-market sales · 50,000 sh · avg $7.97 · $398,460 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-17 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −50,000 | 16,875 | D |
Loading xslF345X05/ownership.xml…